Copenhagen Area, Capital Region, Denmark
Chairman and owner at BLUE Healthcare Investments
Pharmaceuticals
Education
Københavns Universitet 1980 — 1988
M.D., Medicine
Københavns Universitet 1988 — 1990
Ph.D., Pharmacology
Danmarks Tekniske Universitet 2001 — 2003
Executive M.B.A., Innovation Management
Københavns Universitet
Dr.Med.Sci., Medicine
Kellogg School of Management 2009 — 2009
Executive Training, Marketing, Crisis Management
The Hong Kong University of Science and Technology 2010 — 2010
Executive Training, Financial Reporting, Business in Emerging Markets
INSEAD 2012 — 2012
Executive training, Strategy, Leadership
Experience
BLUE Healthcare Investments March 2015 - Present
Medical Prognosis Institute April 2006 - April 2015
Novo Nordisk A/S September 2013 - January 2015
Merck Serono January 2012 - March 2013
Merck Serono June 2008 - December 2011
Zealand Pharma A/S October 1998 - April 2008
University of Copenhagen, Denmark January 1995 - April 2008
H. Lundbeck A/S January 1997 - October 1998
University Hospitals Copenhagen, Denmark 1993 - 1995
The University of Iowa 1990 - 1993
Skills
Leadership, Lifesciences, Drug Delivery, Diabetes, Drug Discovery, Biochemistry, Antibodies, Molecular Biology, R&D, Translational Medicine, Immunology, Neuroscience, Clinical Trials, Technology Transfer, Regulatory Submissions, CTMS, Cancer, CRO, Commercialization, Drug Development, Medicine, Strategy, Biopharmaceuticals, In Vitro, GLP, Biologics, Entrepreneurship, Protein Chemistry, Infectious Diseases, Pharmacology, Biomarkers, Clinical Research, Science, Kidney, Management, Innovation Management, Oncology, Biotechnology, IND, Medical Affairs, Strategic Leadership, Clinical Pharmacology, Cardiovascular Disease, Pharmaceutical Industry, GCP, Regulatory Affairs, Vaccines, Pharmaceutics, Medicinal Chemistry, Clinical Development